Profile
Jens-Peter Volkmer is the founder of Forty Seven, Inc. which was founded in 2014.
He held the title of Vice President-Research & Early Development at the time of founding.
Currently, he is the Chief Executive Officer & Chief Financial Officer at 48 Bio, Inc.
Jens-Peter Volkmer active positions
| Companies | Position | Start |
|---|---|---|
| FORTY SEVEN, INC. | Founder | 2013-12-31 |
48 Bio, Inc.
 48 Bio, Inc. Pharmaceuticals: MajorHealth Technology 48 Bio, Inc. manufactures pharmaceutical and medicine. The CEO of the American company is Jens-Peter Volkmer. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
48 Bio, Inc.
48 Bio, Inc. Pharmaceuticals: MajorHealth Technology 48 Bio, Inc. manufactures pharmaceutical and medicine. The CEO of the American company is Jens-Peter Volkmer. | Health Technology |
- Stock Market
- Insiders
- Jens-Peter Volkmer
